Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1284-1289

  Babu, G Nagesh ^a   Kumar, Alok ^a   Chandra, Ramesh ^b   Puri, S K ^b   Singh, R L ^c   Kalita, Jayantee ^a   Misra, U K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Amyotrophic lateral sclerosis; Antioxidant enzymes; Glucose 6 phosphate dehydrogenase; Glutathione; Lipid peroxidation; Oxidative stress

Indexed keywords

CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 40949149410     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.01.009     Document Type: Article

References (38)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Babu G.N., Bawari M., and Ali M.M. Lipid peroxidation potential and antioxidant status of circumventricular organs of rat brain following neonatal monosodium glutamate. Neurotoxicology 15 (1994) 773-777
3. Babu G.N., Bawari M., Mathur V.N., Kalita J., and Misra U.K. Blood glutamate levels in patients with motor neuron disease. Clin. Chim. Acta 273 (1998) 195-200
4. Bandopadhyay D., Biswas K., Bhattacharyya M., Reiter R.J., and Banerjee R.K. Gastric toxicity and mucosal ulceration induced by oxygen-derived reactive species: protection by melatonin. Curr. Mol. Med. 1 (2001) 501-513
5. Bawari M., Babu G.N., Ali M.M., Misra U.K., and Chandra S.V. Lactate dehydrogenase and glutamate dehydrogenase activities in the circumventricular organs of rat brain following neonatal monosodium glutamate. Experientia 49 (1993) 1092-1094
6. Bawari M., Babu G.N., Ali M.M., and Misra U.K. Effect of neonatal monosodium glutamate on lipid peroxidation in adult rat brain. Neuroreport 6 (1995) 650-652
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Brehe J.E., and Burch H.B. Enzymatic assay for glutathione. Anal. Biochem. 74 (1976) 189-197
9. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron disease/amyotrophic lateral sclerosis of the World Federation of Neurology Research group on neuromuscular disease and the El Escorial 'Clinical limits of amytrophic lateral sclerosis' workshop contributors. J. Neurol. Sci. 124 Suppl. (1994) 96-107
10. Chakraborty D., and Bhattacharyya M. Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin. Chim. Acta 305 (2001) 123-129
11. Chattopadhyay A., Choudhury T.D., Bandopadhyay D., and Datta A.G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem. Pharmacol. 59 (2000) 419-425
12. Chi L., Ke Y., Luo C., Gozal D., and Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144 (2007) 991-1003
13. De M.R., Bard R.C., and Gunsalus I.C. The mechanism of the heterolactic fermentation: a new route of ethanol formation. J. Bacteriol. 62 (1951) 499-511
14. Forstrom J.W., Zakowski J.J., and Tappel A.L. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 17 (1978) 2639-2644
15. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264 (1989) 7761-7764
16. Grimble R.F. Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz. 2 (1994) 175-185
17. Gul M., Kutay F.Z., Temocin S., and Hanninen O. Cellular and clinical implications of glutathione. Indian J. Exp. Biol. 38 (2000) 625-634
18. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
19. Halliwell B., and Gutteridge J.M. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246 (1986) 501-514
20. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186 (1990) 1-85
21. Imlay J.A. Pathways of oxidative damage. Annu. Rev. Microbiol. 57 (2003) 395-418
22. Kletzien R.F., Harris P.K., and Foellmi L.A. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J. 8 (1994) 174-181
23. Kosower N.S., and Kosower E.M. The glutathione status of cells. Int. Rev. Cytol. 54 (1978) 109-160
24. Liang L.P., and Patel M. Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease. J. Neurochem. 90 (2004) 1076-1084
25. Liochev S.I., and Fridovich I. Cross-compartment protection by SOD1. Free Radic. Biol. Med. 38 (2005) 146-147
26. 2-induced neuronal apoptosis. J. Neurochem. 73 (1999) 1181-1188
27. Nikolić-Kokić A., Stević Z., Blagojević D., Davidović B., Jones D.R., and Spasić M.B. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin. Chem. Lab. Med. 44 (2006) 589-593
28. Nishikimi M., Appaji Rao N., and Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 46 (1972) 849-854
29. Norris F.H., Calanchini P.R., Fallat R.J., Panchari S., and Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24 (1974) 721-728
30. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann. Neurol. 28 (1990) 3-8
31. Racker E. Glutathione reductase from bakers' yeast and beef liver. J. Biol. Chem. 217 (1955) 855-865
32. Salvemini F., Franze A., Iervolino A., Filosa S., Salzano S., and Ursini M.V. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J. Biol. Chem. 274 (1999) 2750-2757
33. Scott M.D., Eaton J.W., Kuypers F.A., Chiu D.T., and Lubin B.H. Enhancement of erythrocyte superoxide dismutase activity: effects on cellular oxidant defense. Blood 74 (1989) 2542-2549
34. Siciliano G., Piazza S., Carlesi C., Del Corona A., Franzini M., Pompella A., Malvaldi G., Mancuso M., Paolicchi A., and Murri L. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. J. Neurol. 254 (2007) 575-580
35. Tandan R., and Bradley W.G. Amyotrophic lateral sclerosis. Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 18 (1985) 271-280
36. Tandan R., and Bradley W.G. Amyotrophic lateral sclerosis. Part 2. Etiopathogenesis. Ann. Neurol. 18 (1985) 419-431
37. Tesoriere L., D'Arpa D., Butera D., Allegra M., Renda D., Maggio A., Bongiorno A., and Livrea M.A. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic. Res. 34 (2001) 529-540
38. Utley H.G., Bernheim F., and Hochstein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch. Biochem. Biophys. 118 (1967) 29-32